Renu M Gandhe, MD
Allergy/Immunology · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 30
- 8 carriers
- Office
- 1
Offices
1 location · UCSF Health Medical Foundation · 40 clinicians in this group
Hospitals listed: Dominican Hospital. That is not proof they admit you there this week.
Plans that list them
30 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gandhe’s office at (650) 701-1882 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
30 of 30 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A130447 · Current
Licensed to practise in California · since 2014 · expires 2028-01-31 · Maharashtra University of Health Sciences, Government Medical College, Nagpur.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Dominican HospitalSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative sepsis rate: 11.66 (8.02 to 15.3) · 412 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.169, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.489, Oct 2024 – Sep 2025
See every measure and the patient survey for Dominican Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 11.66 (8.02 to 15.3) · 412 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.169 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.489 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.95) · 1,248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.85 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.37 (94.33 to 174.41) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,973 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 7,510 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,695 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.44 to 5.4) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.76) · 436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.85 (0.4 to 3.29) · 1,474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.73 (3 to 14.46) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.17) · 6,336 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.937 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 212 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 45 · 237 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.5 · 594 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.9 · 510 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 473 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.8) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13 (9.4 to 17.7) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.4 to 15.4) · 1,585 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 390 cases | No different | Jan 2024 – Dec 2024 |
What patients said (774 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 32% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$89,721
Medicare paid this office $89,721 for 202 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 135 | $15,477 | $73 |
| Professional service for preparation and provision of 1 or more antigens | 46 | $15,015 | $15 |
| Test for allergy using allergenic extract | 58 | $13,516 | $3 |
| Return visit (30+ min) | 67 | $9,835 | $102 |
| New patient visit (45+ min) | 56 | $7,872 | $141 |
See all 11 services
| Short return visit (20+ min) | 135 | $15,477 | $73 |
| Professional service for preparation and provision of 1 or more antigens | 46 | $15,015 | $15 |
| Test for allergy using allergenic extract | 58 | $13,516 | $3 |
| Return visit (30+ min) | 67 | $9,835 | $102 |
| New patient visit (45+ min) | 56 | $7,872 | $141 |
| Professional service for multiple injections of allergen | 49 | $7,854 | $11 |
| Test to measure expiratory airflow and volume | 126 | $5,435 | $23 |
| Test to measure the level of nitric oxide gas | 120 | $3,915 | $17 |
| Test for allergy using allergenic extract injected into skin | 40 | $1,903 | $8 |
| New patient visit (30+ min) | 13 | $1,268 | $98 |
| Professional service for single injection of allergen | 12 | $862 | $9 |
Who their Medicare patients are
202 Original Medicare patients in 2024. Average age 73 · Women 69% · Health risk score 0.88. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 58% · Coronary heart disease 23% · Depression 19% · Diabetes 18% · COPD 16% · Chronic kidney disease 12% · Atrial fibrillation 11% · Cancer 10% · Heart failure 8%.
The office billed $434,281, Medicare allowed $120,899 and paid $89,721; for 7,351 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 202 | 7,351 | 73 | 0.88 | $434,281 | $89,721 |
| 2023 | 190 | 7,064 | 73 | 0.95 | $369,469 | $80,842 |
| 2022 | 174 | 3,627 | 72 | 0.95 | $195,399 | $54,680 |
| 2021 | 117 | 8,145 | 73 | 1.00 | $561,626 | $180,094 |
| 2020 | 108 | 5,962 | 73 | 0.99 | $300,581 | $139,603 |
| 2019 | 44 | 829 | 70 | 1.00 | $43,608 | $18,194 |
| 2018 | 108 | 3,714 | 76 | 1.01 | $154,147 | $86,297 |
| 2017 | 77 | 491 | 76 | 0.90 | $29,685 | $18,036 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Test for allergy using allergenic extract | 56 | $15,309 | $4 |
| Professional service for preparation and provision of 1 or more antigens | 47 | $13,873 | $15 |
| Short return visit (20+ min) | 114 | $13,114 | $75 |
| Return visit (30+ min) | 59 | $8,056 | $109 |
| New patient visit (45+ min) | 51 | $7,468 | $146 |
| Professional service for multiple injections of allergen | 49 | $7,004 | $11 |
| Test to measure expiratory airflow and volume | 103 | $4,451 | $24 |
| Test to measure the level of nitric oxide gas | 101 | $3,130 | $17 |
| New patient visit (30+ min) | 27 | $2,557 | $95 |
| Test for allergy using allergenic extract injected into skin | 47 | $2,360 | $8 |
2022: 13 services
| Test for allergy using allergenic extract | 29 | $7,077 | $4 |
| Short return visit (20+ min) | 75 | $7,073 | $81 |
| Return visit (30+ min) | 44 | $4,971 | $106 |
| Professional service for preparation and provision of 1 or more antigens | 18 | $3,846 | $16 |
| New patient visit (45+ min) | 24 | $3,670 | $153 |
| Professional service for multiple injections of allergen | 58 | $3,392 | $12 |
| New patient visit (30+ min) | 17 | $1,668 | $98 |
| Test to measure expiratory airflow and volume | 49 | $1,261 | $25 |
| Injection of drug or substance under skin or into muscle | 14 | $851 | $14 |
| Test for allergy using allergenic extract injected into skin | 13 | $815 | $8 |
| Test to measure the level of nitric oxide gas | 35 | $669 | $19 |
| Test to measure rate of airflow | 12 | $553 | $37 |
| Professional service for single injection of allergen | 11 | $330 | $8 |
2021: 8 services
| Short return visit (20+ min) | 51 | $5,980 | $77 |
| Professional service for multiple injections of allergen | 45 | $5,720 | $11 |
| Professional service for preparation and provision of 1 or more antigens | 19 | $3,667 | $15 |
| Return visit (30+ min) | 21 | $2,730 | $105 |
| Injection of drug or substance under skin or into muscle | 19 | $2,726 | $13 |
| Test for allergy using allergenic extract | 17 | $2,372 | $4 |
| Short return visit | 16 | $1,093 | $48 |
| Professional service for single injection of allergen | 11 | $469 | $8 |
2020: 7 services
| Professional service for preparation and provision of 1 or more antigens | 26 | $10,978 | $15 |
| Short return visit (20+ min) | 48 | $4,866 | $67 |
| Professional service for multiple injections of allergen | 45 | $4,682 | $11 |
| Test for allergy using allergenic extract | 12 | $3,074 | $4 |
| Return visit (30+ min) | 18 | $1,930 | $92 |
| Injection of drug or substance under skin or into muscle | 21 | $1,323 | $14 |
| Professional service for single injection of allergen | 11 | $748 | $9 |
2019: 5 services
| Return visit (30+ min) | 22 | $3,862 | $102 |
| Short return visit (20+ min) | 12 | $2,230 | $70 |
| Test to measure rate of airflow | 16 | $1,219 | $39 |
| Professional service for multiple injections of allergen | 15 | $288 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $226 | $16 |
2018: 8 services
| Diagnostic exam of nasal passages using an endoscope | 46 | $23,250 | $208 |
| Professional service for preparation and provision of 1 or more antigens | 53 | $11,846 | $13 |
| Return visit (30+ min) | 48 | $9,707 | $98 |
| Short return visit (20+ min) | 43 | $6,699 | $64 |
| Professional service for multiple injections of allergen | 51 | $5,664 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 52 | $3,330 | $21 |
| New patient visit (45+ min) | 20 | $2,317 | $116 |
| Professional service for single injection of allergen | 28 | $1,851 | $8 |
2017: 6 services
| Diagnostic exam of nasal passages using an endoscope | 30 | $7,810 | $206 |
| New patient visit (45+ min) | 19 | $2,819 | $148 |
| Professional service for multiple injections of allergen | 53 | $1,934 | $10 |
| Short return visit (20+ min) | 23 | $1,891 | $68 |
| Return visit (30+ min) | 15 | $1,582 | $99 |
| Professional service for single injection of allergen | 30 | $887 | $9 |
Medicaid work
$18,823 in 2022
Medicaid paid $18,823 for 639 billed services this clinician did in 2022, up to 49 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFF/OP EST MAY X REQ PHY/QHP | 550 | $11,361 |
| Short return visit (20+ min) | 64 | $4,601 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 13 | $1,688 |
| New patient visit (45+ min) | 12 | $1,173 |
| 2022 | 639 | 4 | 49 | $18,823 |
| 2021 | 1,074 | 3 | 37 | $37,786 |
| 2020 | 52 | 1 | 15 | $1,436 |
See the largest Medicaid services in earlier years
2021
| OFF/OP EST MAY X REQ PHY/QHP | 861 | $19,856 |
| Short return visit (20+ min) | 172 | $9,799 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 41 | $8,131 |
2020
| OFF/OP EST MAY X REQ PHY/QHP | 52 | $1,436 |
Drugs they prescribed that Part D paid
$330,283
Pharmacies billed $330,283 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 966) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
578 generic and 388 brand-name prescriptions · $330,283 in drug cost · 56 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 112 | $101,377 | $905 |
| Dupixent | 13 | $48,889 | $3,761 |
| Breo Ellipta | 50 | $29,282 | $586 |
| Spiriva Respimat | 13 | $17,641 | $1,357 |
| Incruse Ellipta | 16 | $7,575 | $473 |
See all 24 drugs
| Trelegy Ellipta | 112 | $101,377 | $905 |
| Dupixent | 13 | $48,889 | $3,761 |
| Breo Ellipta | 50 | $29,282 | $586 |
| Spiriva Respimat | 13 | $17,641 | $1,357 |
| Incruse Ellipta | 16 | $7,575 | $473 |
| Symbicort | 13 | $5,878 | $452 |
| Arnuity Ellipta | 22 | $5,315 | $242 |
| Azelastine | 99 | $3,262 | $33 |
| Breyna | 21 | $2,506 | $119 |
| Wixela Inhub | 14 | $2,022 | $144 |
| Montelukast | 135 | $1,506 | $11 |
| Epinephrine | 11 | $1,456 | $132 |
| Ipratropium | 40 | $1,305 | $33 |
| Albuterol Sulfate Hfa | 50 | $1,300 | $26 |
| Levalbuterol Tartrate Hfa | 15 | $804 | $54 |
| Fluticasone Propionate | 47 | $646 | $14 |
| Ventolin Hfa | 11 | $606 | $55 |
| Clarithromycin | 15 | $360 | $24 |
| Omeprazole | 24 | $289 | $12 |
| Famotidine | 12 | $280 | $23 |
| Prednisone | 47 | $216 | $5 |
| Amoxicillin-Clavulanate Potass | 15 | $174 | $12 |
| Hydroxyzine | 13 | $137 | $11 |
| Triamcinolone Acetonide | 11 | $74 | $7 |
Year by year
| 2024 | 966 | 170 | 0% (0) | 40% | $330,283 |
| 2023 | 700 | 153 | 0% (0) | None | $231,996 |
| 2022 | 363 | 111 | 0% (0) | 39% | $129,856 |
| 2021 | 397 | 78 | None | 40% | $133,704 |
| 2020 | 247 | 59 | 0% (0) | 39% | $90,175 |
| 2019 | 182 | 37 | 0% (0) | 46% | $63,323 |
| 2018 | 283 | 52 | 0% (0) | 25% | $36,989 |
| 2017 | 52 | 31 | 0% (0) | 35% | $8,132 |
| 2016 | 399 | 87 | 0% (0) | 53% | $70,741 |
| 2015 | 321 | 89 | 0% (0) | 58% | $69,068 |
| 2014 | 96 | 44 | 0% (0) | 46% | $11,466 |
| 2013 | 127 | 22 | 0% (0) | 50% | $30,367 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Trelegy Ellipta | 68 | $83,220 | $1,224 |
| Breo Ellipta | 53 | $32,282 | $609 |
| Symbicort | 24 | $14,859 | $619 |
| Advair Hfa | 12 | $6,835 | $570 |
| Azelastine | 76 | $2,537 | $33 |
| Montelukast | 113 | $1,878 | $17 |
| Albuterol Sulfate Hfa | 40 | $1,157 | $29 |
| Ipratropium | 24 | $888 | $37 |
| Levalbuterol Tartrate Hfa | 11 | $611 | $56 |
| Clarithromycin | 16 | $592 | $37 |
| Fluticasone Propionate | 14 | $265 | $19 |
| Omeprazole | 21 | $258 | $12 |
| Prednisone | 43 | $198 | $5 |
| Amoxicillin-Clavulanate Potass | 11 | $132 | $12 |
2022: 10 drugs
| Trelegy Ellipta | 27 | $28,177 | $1,044 |
| Symbicort | 23 | $16,050 | $698 |
| Breo Ellipta | 18 | $7,332 | $407 |
| Albuterol Sulfate Hfa | 25 | $1,312 | $52 |
| Azelastine | 22 | $1,276 | $58 |
| Montelukast | 56 | $1,018 | $18 |
| Olopatadine | 13 | $712 | $55 |
| Mupirocin | 12 | $350 | $29 |
| Fluticasone Propionate | 19 | $254 | $13 |
| Prednisone | 12 | $37 | $3 |
2021: 13 drugs
| Dupixent | 11 | $37,427 | $3,402 |
| Breo Ellipta | 26 | $18,114 | $697 |
| Symbicort | 18 | $12,324 | $685 |
| Spiriva Respimat | 14 | $9,192 | $657 |
| Xhance | 15 | $8,661 | $577 |
| Dulera | 11 | $5,666 | $515 |
| Azelastine | 15 | $1,205 | $80 |
| Montelukast | 65 | $1,162 | $18 |
| Albuterol Sulfate Hfa | 19 | $942 | $50 |
| Fluticasone Propionate | 23 | $609 | $26 |
| Prednisone | 21 | $135 | $6 |
| Triamcinolone Acetonide | 11 | $62 | $6 |
| Hydroxyzine | 12 | $57 | $5 |
2020: 4 drugs
| Breo Ellipta | 20 | $12,525 | $626 |
| Montelukast | 41 | $760 | $19 |
| Fluticasone Propionate | 13 | $536 | $41 |
| Albuterol Sulfate Hfa | 11 | $450 | $41 |
2019: 3 drugs
| Spiriva Respimat | 13 | $7,943 | $611 |
| Breo Ellipta | 18 | $7,916 | $440 |
| Montelukast | 32 | $590 | $18 |
2018: 8 drugs
| Advair Diskus | 17 | $13,604 | $800 |
| Azelastine | 14 | $1,468 | $105 |
| Fluticasone Propionate | 28 | $602 | $22 |
| Montelukast | 28 | $477 | $17 |
| Mupirocin | 12 | $289 | $24 |
| Amoxicillin-Clavulanate Potass | 18 | $171 | $9 |
| Prednisone | 36 | $168 | $5 |
| Azithromycin | 11 | $115 | $10 |
2016: 10 drugs
| Advair Diskus | 19 | $12,502 | $658 |
| Symbicort | 35 | $12,454 | $356 |
| Flovent Hfa | 21 | $5,960 | $284 |
| Qvar | 15 | $3,137 | $209 |
| Pulmicort Flexhaler | 14 | $2,852 | $204 |
| Azelastine | 18 | $1,576 | $88 |
| Montelukast | 65 | $1,468 | $23 |
| Proair Hfa | 17 | $1,013 | $60 |
| Ipratropium | 25 | $628 | $25 |
| Fluticasone Propionate | 25 | $503 | $20 |
2015: 8 drugs
| Symbicort | 35 | $11,229 | $321 |
| Advair Diskus | 19 | $10,042 | $529 |
| Nasonex | 28 | $7,738 | $276 |
| Qvar | 16 | $3,056 | $191 |
| Proair Hfa | 29 | $1,477 | $51 |
| Montelukast | 41 | $997 | $24 |
| Fluticasone Propionate | 30 | $537 | $18 |
| Ipratropium | 13 | $405 | $31 |
2014: 2 drugs
| Proair Hfa | 14 | $685 | $49 |
| Fluticasone Propionate | 19 | $335 | $18 |
2013: 4 drugs
| Spiriva | 11 | $2,973 | $270 |
| Symbicort | 12 | $2,897 | $241 |
| Fluticasone Propionate | 17 | $435 | $26 |
| Prednisone | 13 | $45 | $3 |
Money from drug and device companies
$1,548 in 2025
| 2025 | 10 | 84 | None | $1,548 |
| 2024 | 10 | 51 | None | $1,018 |
| 2023 | 10 | 72 | None | $1,360 |
| 2022 | 11 | 41 | None | $725 |
| 2021 | 13 | 62 | None | $1,033 |
| 2020 | 14 | 53 | None | $1,126 |
| 2019 | 10 | 29 | None | $503 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Fasenra | $646 | 20 payments
|
| ARS Pharmaceuticals Operations | Neffy | $334 | 12 payments
|
| GlaxoSmithKline | Nucala | $241 | 25 payments
|
| Genzyme | Dupixent | $92 | 5 payments
|
| Octapharma USA | Cutaquig | $69 | 2 payments
|
| Amgen | Tezspire | $61 | 2 payments
|
See all 70 published payments
| ARS Pharmaceuticals Operations | Meals · 2025-12-18 | Neffy | $28 |
| GlaxoSmithKline | Meals · 2025-12-17 | Nucala | $3 |
| GlaxoSmithKline | Meals · 2025-12-17 | Nucala | $10 |
| Novartis Pharmaceuticals | Meals · 2025-12-12 | Rhapsido | $31 |
| ARS Pharmaceuticals Operations | Meals · 2025-12-10 | Neffy | $9 |
| Genzyme | Meals · 2025-12-04 | Dupixent | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-03 | Fasenra | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-18 | Fasenra | $14 |
| GlaxoSmithKline | Meals · 2025-11-12 | Nucala | $4 |
| ARS Pharmaceuticals Operations | Meals · 2025-11-07 | Neffy | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-05 | Fasenra | $22 |
| Genzyme | Meals · 2025-11-05 | Dupixent | $20 |
| GlaxoSmithKline | Meals · 2025-11-04 | Nucala | $3 |
| GlaxoSmithKline | Meals · 2025-10-16 | Nucala | $4 |
| GlaxoSmithKline | Meals · 2025-10-16 | Nucala | $3 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-15 | Fasenra | $25 |
| ARS Pharmaceuticals Operations | Meals · 2025-10-10 | Neffy | $75 |
| ARS Pharmaceuticals Operations | Meals · 2025-10-07 | Neffy | $3 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-03 | Tezspire | $30 |
| GlaxoSmithKline | Meals · 2025-10-02 | Nucala | $14 |
| GlaxoSmithKline | Meals · 2025-09-25 | Trelegy Ellipta | $10 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-23 | Tezspire | $125 |
| GlaxoSmithKline | Meals · 2025-09-17 | Nucala | $4 |
| GlaxoSmithKline | Meals · 2025-09-17 | Nucala | $2 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-27 | Fasenra | $27 |
| GlaxoSmithKline | Meals · 2025-08-18 | Nucala | $12 |
| Octapharma USA | Meals · 2025-08-08 | Cutaquig | $39 |
| GlaxoSmithKline | Meals · 2025-08-01 | Nucala | $3 |
| GlaxoSmithKline | Meals · 2025-08-01 | Nucala | $4 |
| Genzyme | Meals · 2025-07-31 | Dupixent | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-16 | Fasenra | $17 |
| GlaxoSmithKline | Meals · 2025-07-11 | Nucala | $17 |
| Genzyme | Meals · 2025-07-02 | Dupixent | $22 |
| ARS Pharmaceuticals Operations | Meals · 2025-07-01 | Neffy | $5 |
| GlaxoSmithKline | Meals · 2025-06-24 | Trelegy Ellipta | $11 |
| ARS Pharmaceuticals Operations | Meals · 2025-06-18 | Neffy | $16 |
| GlaxoSmithKline | Meals · 2025-06-13 | Nucala | $3 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-03 | Fasenra | $15 |
| GlaxoSmithKline | Meals · 2025-05-30 | Trelegy Ellipta | $16 |
| GlaxoSmithKline | Meals · 2025-05-29 | Nucala | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-05-28 | Dupixent | $32 |
| Genzyme | Meals · 2025-05-21 | Dupixent | $15 |
| GlaxoSmithKline | Meals · 2025-05-16 | Trelegy Ellipta | $7 |
| Grifols USA | Meals · 2025-05-16 | Xembify | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-15 | Fasenra | $22 |
| GlaxoSmithKline | Meals · 2025-05-08 | Trelegy Ellipta | $10 |
| GlaxoSmithKline | Meals · 2025-05-02 | Nucala | $5 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-25 | Tezspire | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-24 | Fasenra | $28 |
| ARS Pharmaceuticals Operations | Meals · 2025-04-22 | Neffy | $7 |
| GlaxoSmithKline | Meals · 2025-04-17 | Nucala | $32 |
| Octapharma USA | Meals · 2025-04-05 | Cutaquig | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-02 | Fasenra | $23 |
| ARS Pharmaceuticals Operations | Meals · 2025-04-01 | Neffy | $125 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-21 | Tezspire | $33 |
| Amgen | Meals · 2025-03-06 | Actimmune | $28 |
| ARS Pharmaceuticals Operations | Meals · 2025-03-03 | Neffy | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-28 | Airsupra | $35 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-27 | Fasenra | $23 |
| Amgen | Meals · 2025-02-27 | Tezspire | $33 |
| GlaxoSmithKline | Meals · 2025-02-18 | Nucala | $30 |
| GlaxoSmithKline | Meals · 2025-02-14 | Nucala | $3 |
| ARS Pharmaceuticals Operations | Meals · 2025-02-13 | Neffy | $12 |
| GlaxoSmithKline | Meals · 2025-02-12 | Trelegy Ellipta | $12 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-12 | Fasenra | $18 |
| Optinose US | Meals · 2025-02-07 | Xhance | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-21 | Tezspire | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-08 | Fasenra | $21 |
| ARS Pharmaceuticals Operations | Meals · 2025-01-06 | Neffy | $11 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-02 | Fasenra | $102 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,018
| AstraZeneca Pharmaceuticals LP | Fasenra | $528 | 16 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $265 | 16 payments
|
| Novartis Pharmaceuticals | Xolair | $51 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $39 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $31 | 1 payment
|
| Octapharma USA | Cutaquig | $31 | 1 payment
|
| Grifols USA | Xembify | $27 | 1 payment
|
| LEO Pharma | Adbry | $25 | 1 payment
|
| Hikma Pharmaceuticals USA | Ryaltris | $16 | 1 payment
|
| Amgen | Tezspire | $7 | 1 payment
|
2023: $1,360
| GlaxoSmithKline | Nucala | $651 | 24 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $292 | 9 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $84 | 3 payments
|
| Octapharma USA | Cutaquig | $68 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $58 | 2 payments
|
| Genentech USA | Xolair | $57 | 2 payments
|
| Grifols USA | Xembify | $56 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $46 | 2 payments
|
| Optinose US | Xhance | $25 | 1 payment
|
| LEO Pharma | Adbry | $24 | 1 payment
|
2022: $725
| GlaxoSmithKline | Trelegy Ellipta | $299 | 13 payments
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $201 | 8 payments
|
| Regeneron Healthcare Solutions | Dupixent | $37 | 1 payment
|
| ALK-Abello | Odactra | $32 | 1 payment
|
| Amgen | Tezspire | $31 | 1 payment
|
| CSL Behring | Hizentra | $28 | 1 payment
|
| Pfizer | Eucrisa | $23 | 1 payment
|
| Genentech USA | Xolair | $22 | 2 payments
|
| kaleo | Auvi-Q | $20 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $20 | 1 payment
|
| Genzyme | Dupixent | $12 | 1 payment
|
2021: $1,033
| GlaxoSmithKline | Nucala | $310 | 16 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $158 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $117 | 3 payments
|
| OptiNose US | Xhance | $82 | 4 payments
|
| kaleo | Auvi-Q | $72 | 3 payments
|
| Amgen | None | $53 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Aralast | $50 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $50 | 2 payments
|
| Genentech USA | Xolair | $40 | 2 payments
|
| Horizon Therapeutics plc | Actimmune | $38 | 2 payments
|
| Grifols USA | Xembify | $28 | 1 payment
|
| Covis Pharma GmBH | Alvesco | $18 | 1 payment
|
| CSL Behring | Haegarda | $16 | 1 payment
|
2020: $1,126
| GlaxoSmithKline | Nucala | $316 | 14 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $241 | 13 payments
|
| Regeneron Healthcare Solutions | Dupixent | $122 | 5 payments
|
| OptiNose US | Xhance | $81 | 4 payments
|
| ALK-Abello | Odactra | $68 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $64 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $57 | 2 payments
|
| Amgen | Evenity | $46 | 2 payments
|
| CSL Behring | Hizentra | $25 | 1 payment
|
| Horizon Therapeutics plc | Actimmune | $25 | 1 payment
|
| kaleo | Auvi-Q | $22 | 1 payment
|
| Lilly USA | Trulicity | $20 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $20 | 1 payment
|
| Genentech USA | Xolair | $19 | 1 payment
|
2019: $503
| GlaxoSmithKline | Nucala | $179 | 12 payments
|
| Kaleo | Auvi-Q | $68 | 4 payments
|
| OptiNose US | Xhance | $59 | 2 payments
|
| Genzyme | Dupixent | $47 | 2 payments
|
| Genentech USA | Xolair | $39 | 2 payments
|
| Circassia Pharmaceuticals | Niox Vero | $33 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $31 | 2 payments
|
| Shire North American Group | Cuvitru | $18 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $15 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $14 | 1 payment
|
Professional record
- NPI
- 1609138874
- Licence
- CA A130447California A130447: Current · expires 2028-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207K00000X (207K00000X)
- Mailing address
- 3448 Mowry Ave, Fremont, CA, 94538
- NPI first listed
- 2012-06-13
- NPI last updated
- 2018-10-29
This is when the NPI record was last certified, not a medical board exam.